Search

Your search keyword '"TUMINO R."' showing total 164 results

Search Constraints

Start Over You searched for: Author "TUMINO R." Remove constraint Author: "TUMINO R." Database Unpaywall Remove constraint Database: Unpaywall
164 results on '"TUMINO R."'

Search Results

1. Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition

2. RISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012

3. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

4. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

5. Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults

6. EP874 Serologic markers ofChlamydia trachomatisand other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort

8. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case–control and Mendelian randomization study in the European prospective investigation into cancer and nutrition

9. Cancer incidence and mortality trends from 2003 to 2014 in Italy

10. Trends of colorectal cancer incidence and mortality rates from 2003 to 2014 in Italy

11. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort

12. AB0290 Lower educational levels are associated with a higher risk of rheumatoid arthritis in a southern european nested case-control study

14. Trends in incidence of thick, thin and in situ melanoma in Europe

15. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

16. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413]

17. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404]

18. Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD)

19. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

21. Geographical variability in survival of European children with central nervous system tumours

22. Dietary glycemic index, glycemic load, and cancer risk: results from the EPIC-Italy study

23. Alcohol consumption and risk of urothelial cell bladder cancer in the European prospective investigation into cancer and nutrition cohort

24. International incidence of childhood cancer, 2001–10: a population-based registry study

25. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

26. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

27. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

28. Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort

29. P722 Prediagnostic serum vitamin D levels and risk of inflammatory bowel disease: a pan-European, nested case-control study

31. Eating at restaurants, at work or at home. Is there a difference? A study among adults of 11 European countries in the context of the HECTOR* project

32. Meal patterns across ten European countries – results from the European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study

33. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study

34. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study

35. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study

36. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

37. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5

38. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study

39. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5

40. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5

41. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study

42. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study

43. Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study

45. The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods

46. Diabetes and Onset of Natural Menopause

47. Diabetes and onset of natural menopause: results from the European Prospective Investigation into Cancer and Nutrition

48. Fruit and vegetable consumption in relation to hepatocellular carcinoma in a multi-centre, European cohort study

49. An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study

50. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study

Catalog

Books, media, physical & digital resources